A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05

SUMMARY: In this randomized, controlled trial, treatment with once-weekly subcutaneous injection of teriparatide for 72 weeks was found to be associated with a significant reduction in the incidence of morphometric vertebral fractures compared with alendronate in women with primary osteoporosis who...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagino, H., Sugimoto, T., Tanaka, S., Sasaki, K., Sone, T., Nakamura, T., Soen, S., Mori, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563544/
https://www.ncbi.nlm.nih.gov/pubmed/34002252
http://dx.doi.org/10.1007/s00198-021-05996-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563544/
https://www.ncbi.nlm.nih.gov/pubmed/34002252
http://dx.doi.org/10.1007/s00198-021-05996-2

Ejemplares similares